Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jviromet.2020.113925 http://scihub22266oqcxt.onion/10.1016/j.jviromet.2020.113925 32659240!7351036!32659240     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Virol+Methods 2020 ; 284 (ä): 113925 Nephropedia Template TP {{tp|p=32659240|t=2020. Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay |pdf=|usr=}}{{32659240}} gab.com Text Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay JO: J Virol Methods http://www.kidney.de/pget.php?&tw=1&pmid=32659240 #FOAvip The clinical and epidemiologic management of the SARS-CoV-2 pandemic is critically dependent on molecular assays with short turn-around time. We validated the novel Xpert Xpress SARS-CoV-2 assay using a commercial nucleic acid testing (Roche Cobas 6800). We found an excellent concordance over a range of SARS-CoV-2 loads and across established human coronaviruses. Twit Text FOAVip Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay ????J Virol Methods http://www.kidney.de/pget.php?&tw=1&pmid=32659240 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32659240 #FOAvip English Wikipedia <ref>{{Cite pmid|32659240}}</ref> Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay #MMPMID32659240 Goldenberger D; Leuzinger K; Sogaard KK; Gosert R; Roloff T; Naegele K; Cuenod A; Mari A; Seth-Smith H; Rentsch K; Hinic V; Hirsch HH; Egli A J Virol Methods 2020[Oct]; 284 (ä): 113925 PMID32659240show ga The clinical and epidemiologic management of the SARS-CoV-2 pandemic is critically dependent on molecular assays with short turn-around time. We validated the novel Xpert Xpress SARS-CoV-2 assay using a commercial nucleic acid testing (Roche Cobas 6800). We found an excellent concordance over a range of SARS-CoV-2 loads and across established human coronaviruses. |Betacoronavirus/genetics/*isolation & purification[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Clinical Laboratory Techniques/instrumentation/*methods/standards[MESH] |Coronavirus Infections/diagnosis/*virology[MESH] |Diagnostic Tests, Routine[MESH] |Humans[MESH] |Nasopharynx/virology[MESH] |Pandemics[MESH] |Pneumonia, Viral/diagnosis/*virology[MESH] |Polymerase Chain Reaction/instrumentation/methods[MESH] |Reproducibility of Results[MESH] |SARS-CoV-2[MESH]Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay (epmc).pdf DeepDyve Pubget Overpricing